Dr. Mark Ferguson is a thoracic and cardiac surgeon in the Department of Surgery at the University of Chicago Comprehensive Cancer Center. His surgical specialty is the management of lung, esophageal, and thymus diseases. He is experienced in all techniques of lung and esophageal resection, as well as the management of malignant pleural effusions. Dr.
Dr. Jessica S. Donington is a thoracic surgeon and clinical researcher whose particular interests and skills are the treatment of lung, esophageal, and mediastinal conditions. As Chief of the University of Chicago’s Department of Surgery’s Thoracic Surgery section, she specializes in the multidisciplinary care of both benign and malignant chest diseases, including lung cancer and
Dr. Ankit Bharat is a board-certified thoracic surgeon and general surgeon whose clinical focus is on the treatment of malignant and benign chest diseases, including lung cancer and malignant pleural mesothelioma. He is the Chief of Thoracic Surgery at Lurie Cancer Center and Northwestern Medicine, as well as the Harold L. and Margaret N. Method
A follow-up survey conducted by the National Comprehensive Cancer Network (NCCN) has revealed that though shortages of chemotherapy drugs are continuing, they are having little to no impact on mesothelioma patients and others diagnosed with other cancers. Experts attribute this to the adoption of strict protocols and strategies regarding the use of available resources. Chemotherapy Drug Shortages
The International Association for the Study of Lung Cancer held its 2023 World Conference on Lung Cancer last week, and much of the information presented focused on discoveries in malignant mesothelioma. One clinical trial’s results were presented focused on the importance of dendritic cells and how they can be leveraged to stimulate immune responses.
Dr. Mohamed E. Abazeed is a radiation oncologist and scientist dedicated to improving outcomes for patients with lung cancer and other tumors, including malignant pleural mesothelioma. He is the Co-Leader of the Lurie Cancer Center at Northwestern Health, Associate Professor of Medicine at Northwestern University, and an active member of the Translational Research in Solid
Dr. Momen Wahidi is an internationally respected expert in interventional pulmonology and bronchoscopy with a special interest in patients with lung cancer and pleural diseases, including malignant pleural mesothelioma and interstitial lung disease. He is the Medical Director for the Canning Thoracic Institute and Health System Director for Interventional Pulmonology at the Robert H. Lurie
Dr. Jyoti D. Patel is a thoracic oncologist and professor of medicine at the Robert H. Lurie Comprehensive Cancer Center and Northwestern University Medical School. As Director of Thoracic Oncology, she oversees all lung cancer clinical and research activities at the facility and has been instrumental in developing clinical guidelines for the treatment of lung
Jennifer W. Carlisle, MD is a medical oncologist at the Winship Cancer Institute at Emory University Hospital. She provides direct care for patients diagnosed with lung cancer, malignant pleural mesothelioma, and other thymic cancers, while also advancing clinical trials, collaborating on detailed immunologic correlative studies, and teaching medical students, residents, and fellows as an Associate
As a thoracic medical oncologist, Dr. Ticiana Leal specializes in the care of patients diagnosed with malignant pleural mesothelioma, lung cancer, and thymic malignancies. She is the Director of the Thoracic Medical Oncology Program at the Winship Cancer Institute of Emory University Hospital. Winship Cancer Institute is the only NCI-designated comprehensive cancer center in the